| |
Implantationa
|
Clinical Pregnancya
|
|---|
| |
Fine Adjusted OR (95 % CI)
|
P value
|
Fine Adjusted OR (95 % CI)
|
P value
|
|---|
|
CsA
|
1.251 (0.739–2.120)
|
0.404
|
1.634 (0.772–3.458)
|
0.199
|
|
Patients’ age at OPU (y)
|
0.579 (0.399–0.841)
|
0.004
|
0.411 (0.234–0.721)
|
0.002
|
|
Patients’ age during ET (y)
|
1.589 (1.097–2.303)
|
0.014
|
2.149 (1.233–3.745)
|
0.007
|
|
BMI (kg/m2)
|
1.078 (1.005–1.157)
|
0.036
|
1.069 (0.966–1.183)
|
0.195
|
|
No. of ET cycles
|
0.584 (0.344–0.993)
|
0.047
|
0.641 (0.315–1.307)
|
0.222
|
|
No. of embryos transferred
|
0.515 (0.243–1.092)
|
0.083
|
2.171 (0.924–5.099)
|
0.075
|
|
Endometrium thickness(mm)
|
0.976 (0.866-1.100)
|
0.690
|
0.910 (0.773–1.072)
|
0.261
|
|
Embryo stage
|
1.546 (0.945–2.530)
|
0.083
|
1.904 (0.937–3.867)
|
0.075
|
- CsA Cyclosporin A; OPU oocyte pick-up; ET embryo transfer; BMI body mass index. a Fine Adjusted for age, BMI, number of ET cycles, number of ET embryos, endometrium thickness and embryo stage.Multivariate analysis included variables with univariate P value ≤ 0.10 and confounders those were known and potential
